JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 5, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/41/37967    most recent
M105365200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alonso, A. D.
Right arrow Articles by Iqbal, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonso, A. D.
Right arrow Articles by Iqbal, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print August 8, 2001
J. Biol. Chem, 10.1074/jbc.M105365200
Submitted on June 11, 2001
Revised on August 3, 2001
Accepted on August 7, 2001

Tau isoforms: Interaction with Alzheimer disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein

Alejandra D. Alonso, Tanweer Zaidi, Michal Novak, Héctor S. Barra, Inge Grundke-Iqbal, and Khalid Iqbal

Department of Neurochemistry, NY State Institute for Basic Research, Staten Island, NY 10314

Corresponding Author: kiqbal{at}admin.con2.com

The microtubule associated protein tau is a family of six isoforms that becomes abnormally hyperphosphorylated and accumulates in neurons undergoing neurodegeneration in the brains of patients with Alzheimer disease (AD) . We investigated the isoform specific interaction of normal tau with the AD hyperphosphorylated tau (AD P-tau). We found that the binding of AD Ptau to normal human recombinant tau was t4L > t4S > t4 >; t3L, > t3S > t3 and that its binding to t4L was greater than to t3L. AD Ptau also inhibited the assembly of microtubules promoted by each tau isoform, and caused disassembly when added to preassembled microtubules. This inhibition and depolymerization of microtubules by the AD Ptau corresponded directly to the degree of its interaction with the different tau isoforms. In vitro hyperphosphorylation of recombinant tau (P-tau) conferred AD P-tau-like characteristics. Like AD P-tau, P-tau interacted with and sequestered normal tau and inhibited microtubule assembly. These studies suggest that the AD Ptau interacts preferentially with the tau isoforms that have the amino terminal inserts and four microtubule binding domain repeats and that hyperphosphorylation of tau appears to be sufficient to acquire AD P-tau characteristics. Thus, lack of amino terminal inserts and extra microtubule binding domain repeat in fetal human brain might be protective from Alzheimer neurofibrillary degeneration.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.